XML 61 R49.htm IDEA: XBRL DOCUMENT v3.25.1
Issuances of Common Shares and Warrants (Detail Narrative) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Jan. 13, 2025
Jan. 07, 2025
Dec. 09, 2024
Oct. 16, 2024
Oct. 01, 2024
Feb. 28, 2025
Nov. 27, 2024
Feb. 28, 2025
Feb. 29, 2024
Aug. 31, 2024
Agreed to cancelled, share purchase warrants               2,977,830    
Description of incentives plan               The Company established an Equity Incentive Plan whereby our Board, pursuant to shareholder approved amendments, may grant up to 1,745,259 stock options, restricted stock awards or restricted stock units to directors, officers, employees, and consultants with such number being increased to up to 10% of the issued share capital at the end of each calendar year, at the discretion of the board, pursuant to an evergreen formula    
Number of shares issued           17,559,179   17,559,179   15,810,205
Proceeds from issuance of common stock               $ 4,357,113 $ 4,208,731  
Stock based compensation expense               $ 266,634 $ 53,953  
Stock Options                    
Number of shares granted               142,000   696,500
Exercise price               $ 2.91   $ 2.91
Exercise price repriced               $ 3.47    
Non-vested stock options               232,000    
Unrecognized non-cash stock-based compensation expense           $ 678,493   $ 678,493    
Weighted average remaining contractual life               1 year 9 months 7 days    
Two employees [Member]                    
Number of shares granted         62,000          
Exercise price         $ 3.17          
Weighted average remaining contractual life         5 years          
two Scientific Advisor Board [Member]                    
Number of shares granted             20,000      
Exercise price             $ 2.10      
Weighted average remaining contractual life             5 years      
Scientific Advisory Board And Consultant [Member]                    
Number of shares granted 50,000                  
Exercise price $ 2.07                  
Weighted average remaining contractual life 5 years                  
Scientific Advisory Board [Member]                    
Number of shares granted     10,000              
Exercise price     $ 2.42              
Weighted average remaining contractual life     5 years              
ATM offering [Member]                    
Number of shares issued           6,585   6,585    
Proceeds from issuance of common stock           $ 11,720        
Deferred offering costs           $ 94,000   $ 94,000    
Incentive Equity Plan [Member]                    
Restricted stock granted during period   100,000                
Fair value of restricted stock granted during period   $ 224,000                
On October 2024 [Member] | ATM offering [Member]                    
Gross proceeds       $ 26,146            
Common stock shares sold       8,402            
Atm share issuance costs       $ 144,812            
On October 16, 2024 [Member]                    
Gross proceeds       5,000,000.0            
Net proceeds       $ 4,500,000            
Agreed to cancelled, share purchase warrants       2,917,032            
Description of warrant issuance       We also issued the placement agent warrants to purchase up to 57,190 shares at an exercise price of $3.825 per share            
Issued share purchase warrants       4,551,019            
Purchase common stock shares       4,551,019            
Common stock shares sold       1,633,987            
Common stock price per share       $ 3.06            
Purchase price       3.06            
Exercise price       $ 4.75